Metformin reduces abortion in pregnant women with polycystic ovary syndrome (Q34590034)

3 August 2017

title

Metformin reduces abortion in pregnant women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

3 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

Sherif Khattab

1 reference

3 August 2017

Iman Abdel Mohsen

1 reference

3 August 2017

Ismail Aboul Foutouh

1 reference

3 August 2017

Ashraf Ramadan

1 reference

3 August 2017

Mohamed Moaz

1 reference

3 August 2017

Hesham Al-Inany

1 reference

3 August 2017

publication date

1 December 2006

1 reference

Gynecological Endocrinology

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

680-684

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Hypersecretion of luteinizing hormone and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Hypersecretion of luteinising hormone, infertility, and miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Obesity is a risk factor for early pregnancy loss after IVF or ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Genetic hypofibrinolysis in complicated pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Identification of placental protein 14 as an immunosuppressive factor in human reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Suppression by Human Placental Protein 14 of Natural Killer Cell Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Metformin administration improves endothelial function in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Outcome of clinical pregnancies after ovulation induction using metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590601010508

10.1080/09513590601010508

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference